Patient Education
When your surgeon
uses CaverMap, they are taking the best diagnostic steps to improve
the risks associated with your prostate procedures outcome. Ask your
doctor about CaverMap.
Prostate Cancer
Treatment
Prostate cancer is most often contained
locally within the prostate. The "Gold Standard" treatment for localized
prostate cancer is radical prostatectomy. Removing the entire prostate
and any local surrounding cancer, is a surgeon's primary goal. The
operation's most common complications are impotence and incontinence, caused by damage
to the nerves around the prostate.
Urologists developed nerve-sparing surgical
techniques to preserve a man's potency. While this technique increase chances
for maintaining function, its effectiveness ranges from 11% to 86%, depending on
the surgical skill and patient's age.* A surgeon's standards and practice
frequency are important to accepted outcomes.
Our CaverMap technology helps surgeons improve their
diagnosis standards. When CaverMap is effectively utilize, it supports
navigation around vital nerve bundles, sparing them damage.
The CaverMap Surgical Aid provides a nerve performance measured analysis.
It assists the surgeon in locating and mapping the prostate surrounding
cavernous nerves, which conduct erectile function.* When a surgeon truly
diagnoses where the working nerves are, they are better able to decide where to cut
and keep the nerves intact.
After the prostate is removed, the CaverMap
Surgical Aid
allows surgeons to measure and confirm nerve function for immediate feedback on
likely outcomes and additional available therapies.
Research
A
recent multi-center research study at major cancer centers evaluated the
CaverMap Surgical Aid for the past 4 years and treated 61 patients.
A full 92% of the men who had normal erectile
function before surgery, continued to have erections in the measured year
after surgery. This represents a dramatic improvement over previous unaided
radical prostatectomy surgical results, which were approximately 30 percent.*
Indications
and Availabilities
Men
who have localized prostate cancer and normal erectile function may benefit from
radical prostatectomy surgery with the CaverMap Surgical Aid. Prostate cancer
patients should speak with their urologist to determine if the CaverMap
Surgical Aid could be of benefit to them.
CaverMap
is now commercially available nationwide at many leading prostate cancer treatment centers.
For more information, ask your doctor about CaverMap.
For current hospital listing please see our website:
www.bluetorchmed.com
Call us directly at 508-231-1080, or
email us sales @ bluetorchmed.com.
The Facts
Prostate cancer is the most common internal malignancy among American
men,
according to the American Cancer Society.
Prostate
cancer incidence rates have increased 50 percent from 1989 to 1993, and by
the end of 1999 approximately 200,000 new prostate cancer cases will be
diagnosed.* This increase is due to
greater disease awareness and early detection. More
Information For further
information regarding prostate cancer, please consult with your physician.
CaverMap®
Surgical Aid Caution: Federal
(USA) law prohibits sale unless made by or on the order of a physician
trained in prostate surgery. * Data on file
This device is designed as an
adjunct to current prostatectomy procedures in which nerve sparing
technique is used. It is not designed to replace the surgeon's expertise
in mapping out neurovascular bundles. This
information is for general information purposes only. We recommend you
consult with your physician. This is not a substitute for medical care,
nor a means of rendering medical advice.
CaverMap is Blue Torch trademark.
© Blue Torch 2007. All rights reserved.
Back to Top
|
